Differentiated drug products enabled by microgravity
Processing in a microgravity environment dramatically alters buoyancy, natural convection, sedimentation, phase separation, driving significant differences in transport-driven phenomena.
Varda’s microgravity platform enables unique formulations of small molecules and biologics, providing innovative solutions to industry challenges and unlocking new opportunities in therapeutic development.
Processing materials in microgravity, or the near-weightless conditions found in space, offers a unique environment not available through terrestrial processing. These benefits primarily stem from the lack of convection and sedimentation.
These effects are “locked” into the material, typically through material crystallization, before being brought back to Earth.
Varda’s microgravity platform offers direct access to processing in the microgravity of low Earth orbit. Microgravity offers the ability to eliminate factors such as natural convection and sedimentation. Processing in a microgravity environment provides a path to formulating small molecules and biologics that traditional manufacturing processes cannot address. The resulting tunable particle size distributions, more-ordered crystals, and novel forms can lead to improved bioavailability, extended shelf-life, novel intellectual property, and innovative routes of administration.